Purpose: The management of thyroid nodules of indeterminate cytology is controversial. Our study aimed to establish the frequency and significance of promoter, and gene mutations in thyroid nodes of indeterminate cytology and to assess their potential usefulness in clinical practice.
Methods: -,-, promoter and gene mutations were examined in a series of 199 consecutive nodes of indeterminate cytology referred for surgical excision.
Results: 69/199 (35%) were malignant on histopathological review. mutations were detected in 36/199 (18%), and 19/36 cases (53%) were malignant on histological diagnosis. promoter mutations were detected in 7/199 (4%) nodules, which were all malignant lesions. mutations were detected in 15/199 (8%), and a K601E mutation was identified in 2 follicular adenomas and 1 noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Altogether, this panel was able to identify 48% of the malignant lesions, achieving a specificity, positive predictive value, and negative predictive value for malignancy of 85, 62, and 75%, respectively.
Conclusion: The residual malignancy risk in mutation-negative nodes is 25%. These nodes still need to be resected, but mutation analysis could help to orient the appropriate surgical strategy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650698 | PMC |
http://dx.doi.org/10.3389/fendo.2017.00273 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!